Report - Annex III Summary of product characteristics, labelling ......Cholelithiasis is a very common event during Sandostatin treatment and may be associated with cholecystitis and biliary

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form